Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2006
09/26/2006US7112722 nucleotide sequence or complements that code polypeptides having synthetase enzyme activity, used to alter enzyme levels in transformed host cells
09/26/2006US7112718 Transgenic plants synthesizing high amylose starch
09/26/2006US7112717 Homogentisate prenyl transferase gene (HPT2) from arabidopsis and uses thereof
09/26/2006US7112667 Sequences of an Ih ion channel and use thereof
09/26/2006US7112666 Von Willebrand Factor (Vwf)-cleaving protease
09/26/2006US7112665 Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants
09/26/2006US7112661 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha
09/26/2006US7112654 Ligand for vascular endothelial growth factor receptor
09/26/2006US7112653 Composition and method for preserving progenitor cells
09/26/2006US7112562 Insulin conjugates and methods of use thereof
09/26/2006US7112441 Propagation and encapsulating preerential objects in culture; prepare nutrient broth, incoculate with encapaulated object, propagate in absence of gravity
09/26/2006US7112440 Method of increasing the relative number of CD45 low cells in a cell population
09/26/2006US7112439 Dual expression vector system for antibody expression in bacterial and mammalian cells
09/26/2006US7112437 Stability; maintenance in culture
09/26/2006US7112436 Conjugate for modifying interactions between proteins
09/26/2006US7112430 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
09/26/2006US7112428 hydroxycarboxylic ester asymmetric hydrolase (EnHCH); genetic engineering; optical actvity; for medicines, agricultural chemicals, and strongly dielectic liquid crystal
09/26/2006US7112427 Protein comprising mitogenic kinase activity for identifying modulators of inflammation, apoptosis and cell proliferation; antiproliferative agents
09/26/2006US7112426 Human cAMP-dependent protein kinase beta-catalytic subunit
09/26/2006US7112425 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives
09/26/2006US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto
09/26/2006US7112418 Ion channel
09/26/2006US7112415 Method of preparing cell cultures from biological specimens for assaying a response to an agent
09/26/2006US7112324 CD 19×CD3 specific polypeptides and uses thereof
09/26/2006US7112218 Tissue engineered blood vessels and apparatus for their manufacture
09/26/2006CA2345903C Molecular pathogenicide mediated plant disease resistance
09/26/2006CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof
09/24/2006CA2516364A1 Method of modulation
09/21/2006WO2006099480A2 Stress proteins and peptides and methods of use thereof
09/21/2006WO2006099178A2 Predictive scoring function for estimating binding affinity
09/21/2006WO2006099152A2 Slow-maturing, determinate peas
09/21/2006WO2006099030A2 Methods of islet isolation and transplantation
09/21/2006WO2006098952A2 Corn event 3272 and methods of detection thereof
09/21/2006WO2006098901A2 Influenza hemagglutinin and neuraminidase variants
09/21/2006WO2006098488A1 Method of ameliorating symptom caused by mood disturbance
09/21/2006WO2006098485A1 Glutamate decarboxylase mutant
09/21/2006WO2006098423A1 Polynucleotides imparting environmental stress-tolerance to plants
09/21/2006WO2006098332A1 Promoter for hard tissue formation
09/21/2006WO2006098314A1 Novel sugar uptake activator and method for screening the same
09/21/2006WO2006098225A1 Method of constructing plant having nodules with high nitrogen fixation activity
09/21/2006WO2006098040A1 Method for production of recombinant dna molecule
09/21/2006WO2006097743A2 Method for actvating natural killer cells by tumor cell preparation in vitro
09/21/2006WO2006097740A1 Capillary devices for cell and non-human embryo culture
09/21/2006WO2006097708A2 Affinity purification of protein
09/21/2006WO2006097707A2 Skin composition treatment
09/21/2006WO2006097701A2 Skin equivalent culture
09/21/2006WO2006097110A2 Polypeptides having antimicrobial activity and polynucleotides encoding same
09/21/2006WO2006096931A1 Renal repair and regeneration
09/21/2006WO2006076567A3 Microfluidic rare cell detection device
09/21/2006WO2006073692A3 Isolation and purification of human insulin producing cells for the treatment of insulin dependent diabetes
09/21/2006WO2006067232A3 Plants having increased yield and method for making the same
09/21/2006WO2006031267A3 Rna interference suppression of neurodegenerative diseases and methods of use thereof
09/21/2006WO2005077105A3 Reduction of hiv-1 replication by a mutant apolipoprotein b mrna editing enzyme-catalytic polypeptide-like 3 g (apobec3g)
09/21/2006WO2005067620A8 ANTIBODIES TO MAdCAM
09/21/2006WO2004094616A3 Silencing transcription by methylation
09/21/2006WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2006WO2004078956A3 Process for detaching confluent cells from two dimensional microsupports and its application for preparing transplants
09/21/2006US20060212971 Nucleotide sequences mediating male fertility and method of using same
09/21/2006US20060212970 Plant regulatory sequences for selective control of gene expression
09/21/2006US20060212969 Nucleotide sequences coding enzymatic protein for use in the generation of disease and stress resistant plants
09/21/2006US20060212968 High pigment golden beets
09/21/2006US20060212967 For breeding highly efficient and stable antiviral transgenic plants
09/21/2006US20060212966 Root-preferred, nematode-inducible soybean promoter and its use
09/21/2006US20060212965 AXMI-018, AXMI-020, and AXMI-021, a family of delta-endotoxin genes and methods for their use
09/21/2006US20060212961 Rice transposon gene
09/21/2006US20060212959 Transposase and method of gene modification
09/21/2006US20060212958 cis-element of Oryzias Latipes Tol2 element (inverted terminal repeat sequences); plasmids
09/21/2006US20060212957 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf GENE 1
09/21/2006US20060212956 Animal model of ligand activated HER2 expressing tumors
09/21/2006US20060212953 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
09/21/2006US20060212951 ProCre nucleic acid construct comprising germline-specific promoter operatively associated with a recombinase coding sequence; facilitate production of subtle, conditional, or tissue-specific mutations in mice; genetic expression and engineering
09/21/2006US20060212950 Inducible small rna expression constructs for targeted gene silencing
09/21/2006US20060212125 Bone repairing material using a chondrocyte having the potential for hypertrophy and a scaffold
09/21/2006US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
09/21/2006US20060211117 Methods of making minicircles
09/21/2006US20060211116 Transposase and method of gene modification
09/21/2006US20060211115 Methods of generating chimeric adenoviruses and uses for such chimeric aden oviruses
09/21/2006US20060211113 Method and system for introducing a gene into a human stem cell
09/21/2006US20060211112 Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads
09/21/2006US20060211111 Compositions and methods for neural cell production and stabilization
09/21/2006US20060211110 Expresses transcripts for SSEA-1, SSEA-3, SSEA-4, Oct4, FGF4 and FGFR2, and has a normal karyotype; diabetes
09/21/2006US20060211109 Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells
09/21/2006US20060211108 Methods and compositions for impairing multiplication of HIV-1
09/21/2006US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay
09/21/2006US20060211093 Membrane scaffold proteins and embedded membrane proteins
09/21/2006US20060211092 Membrane scaffold proteins and tethered membrane proteins
09/21/2006US20060211091 MAGE-A3 peptides presented by HLA class II molecules
09/21/2006US20060211088 Method for generating variable domain sequences of heavy chain antibodies
09/21/2006US20060210991 Interleukin-8 homologous polypeptides and therapeutic uses thereof
09/21/2006US20060210974 Compositions and methods for preventing, treating and diagnosing diabetes
09/21/2006US20060210969 used in identifying anti-HCV therapeutic agents, as well as sequences of HCV associated with HCV pathogenesis; drug screening
09/21/2006US20060210965 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
09/21/2006US20060210963 Induction of a Beta Cell Differentiation in Human Cells
09/21/2006US20060210960 Method for processing and preserving collagen-based tissues for transplantation
09/21/2006US20060210596 Seeding implantable medical devices with cells
09/21/2006US20060210595 Device containing cytophilic islands that adhere cells separated by cytophobic regions
09/21/2006US20060210591 Immunization of an individual against carcinomas and the preliminary stages thereof
09/21/2006US20060210577 isolated nucleic acid molecule encoding polypeptide as antitumor biodrugs; monoclonal antibody; modulation of chemokine, cytokine expression; transfected host cell; anticarcinogenic agents
09/21/2006US20060210575 Cytotoxic protein and utilization thereof
09/21/2006US20060210573 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines; monoclonal, polyclonal, recombinant, synthetic intact antibody and Fv, F(ab'), F(ab')2 and single chain antibody fragments; polynucleotides